Literature DB >> 28613229

Measuring Severity of Anxiety and Depression in Patients with Inflammatory Bowel Disease: Low Concordance Between Patients and Male Gastroenterologists.

Neha Janmohamed1, A Hillary Steinhart.   

Abstract

BACKGROUND: Studies have indicated that anxiety and depression are significant contributors to reporting of increased disease activity in patients with inflammatory bowel disease (IBD). Thus, for the appropriate clinical management of these patients, it is important that gastroenterologists are able to recognize these conditions. This study aimed to examine the level of agreement between gastroenterologists and patients with IBD for the presence of clinically significant anxiety and depression.
METHODS: Before consultation, patients completed the Hospital Anxiety and Depression Survey. After the consultation, the gastroenterologist recorded whether they believed the patient was anxious and depressed and if so, whether any further action had been taken.
RESULTS: Seventy-five patients participated in this study, with a response rate of 88%. Self-reported questionnaires indicated that 31% and 11% of patients were identified as probable for having anxiety and depression, respectively. The level of agreement between the patient and gastroenterologist as to the presence of anxiety or depression was fair to moderate (kappa statistic 0.32 and 0.41, respectively). In only 50% of cases was further action taken by gastroenterologists during consultation for distressed patients, mostly in the form of a patient discussion.
CONCLUSIONS: Agreement between gastroenterologists and IBD patients regarding the presence of clinically significant anxiety or depression was low, with no further action taken after consultation for 50% of patients who were identified by gastroenterologists as being anxious or depressed. This study highlights the need for educating gastroenterologists to improve their ability to identify IBD patient distress.

Entities:  

Mesh:

Year:  2017        PMID: 28613229     DOI: 10.1097/MIB.0000000000001107

Source DB:  PubMed          Journal:  Inflamm Bowel Dis        ISSN: 1078-0998            Impact factor:   5.325


  4 in total

Review 1.  Patient Reported Outcomes in Chronic Inflammatory Diseases: Current State, Limitations and Perspectives.

Authors:  Florian Tran; Jan Henrik Schirmer; Ilka Ratjen; Wolfgang Lieb; Philip Helliwell; Johan Burisch; Juliane Schulz; Florian Schrinner; Charlot Jaeckel; Ulf Müller-Ladner; Stefan Schreiber; Bimba F Hoyer
Journal:  Front Immunol       Date:  2021-03-18       Impact factor: 7.561

2.  Depression and Anxiety Disorders Impact in the Quality of Life of Patients with Inflammatory Bowel Disease.

Authors:  Jesús K Yamamoto-Furusho; Katya E Bozada Gutiérrez; Andrea Sarmiento-Aguilar; Ana Fresán-Orellana; Perla Arguelles-Castro; Mario García-Alanis
Journal:  Psychiatry J       Date:  2021-10-27

3.  Association between antidepressant medication use and steroid dependency in patients with ulcerative colitis: a population-based study.

Authors:  Jonathan Blackwell; Christopher Alexakis; Sonia Saxena; Hanna Creese; Alex Bottle; Irene Petersen; Matthew Hotopf; Richard C G Pollok
Journal:  BMJ Open Gastroenterol       Date:  2021-05

4.  The Relationship Between Autonomic Dysfunction of the Gastrointestinal Tract and Emotional Distress in Patients With Systemic Sclerosis.

Authors:  Dana DiRenzo; James Russell; Clifton O Bingham; Zsuzsanna McMahan
Journal:  J Clin Rheumatol       Date:  2021-01-01       Impact factor: 3.902

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.